Reason for request
Extension of indication
Clinical Benefit
| Substantial |
Substantial in type 1 diabetes in children aged 2 to 5 years. |
Clinical Added Value
| no clinical added value |
LANTUS provides no improvement in actual benefit (IAB V, non-existent) in the management of children aged 2 to 5 years with type 1 diabetes. |
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
czZCddQZtddj8qV4
Listen
